(R)-Elsubrutinib structure
|
Common Name | (R)-Elsubrutinib | ||
|---|---|---|---|---|
| CAS Number | 1643570-23-3 | Molecular Weight | 297.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H19N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (R)-Elsubrutinib(R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1]. |
| Name | (R)-Elsubrutinib |
|---|
| Description | (R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al. |
| Molecular Formula | C17H19N3O2 |
|---|---|
| Molecular Weight | 297.35 |